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ANNE B. CURTIS, MD, FACC, LUIZ BELARDINELLI, MD, DAVID A. WOODARD, MD,
CHRISTOPHER S. BROWN, MD, JAMIE B. CONTI, MD, FACC
Gainesville, Florida
Objectives. This study sought to evaluate the sensitivity of fast
and slow atrioventricular (AV) node pathways to incremental
doses of adenosine in patients with typical AV node reentrant
tachycardia.
Background. Although adenosine is known to depress conduc-
tion through the AV node, the relative sensitivity to adenosine of
the anterograde fast and slow pathways in patients with dual AV
node pathways and typical AV node reentrant tachycardia has not
previously been studied.
Methods. Sixteen patients with dual AV node physiology and
typical AV node reentrant tachycardia and 10 control patients
were given incremental doses of adenosine during atrial pacing.
Results. In 14 of 16 patients with dual-AV node physiology,
administration of small doses of adenosine during atrial pacing
led consistently to transient block of impulse conduction in the
fast pathway before block in the slow pathway, resulting in abrupt
prolongation of the AH interval with continued 1:1 AV conduction.
The mean (6SD) doses of adenosine required to cause conduction
block in the fast and slow pathways were 2.7 6 3.0 and 7.2 6
4.7 mg, respectively (p 5 0.004). In 9 of 16 patients, administra-
tion of low dose adenosine led to initiation of AV node reentrant
tachycardia. The control patients showed no abrupt increases in
AH interval with administration of adenosine during atrial pac-
ing.
Conclusions. In most patients with dual AV node pathways and
typical AV node reentrant tachycardia, the fast pathway is more
sensitive than the slow pathway to the effects of adenosine.
(J Am Coll Cardiol 1997;30:1778–84)
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A great deal of evidence has accumulated from basic and
clinical studies (1,2) that the compact atrioventricular (AV)
node has dual inputs located anteriorly and posteriorly. In
patients with AV node reentrant tachycardia, the anterior
pathway in general is a rapidly conducting pathway with a long
refractory period, whereas the posterior pathway is slowly
conducting and has a shorter refractory period (3).
Adenosine is an endogenous nucleoside that slows the sinus
heart rate (negative chronotropic effect) as well as impulse
conduction through the AV node (negative dromotropic ef-
fect). Adenosine is highly effective in terminating supraventric-
ular tachycardias in which the AV node is part of a reentrant
circuit (4). In typical AV node reentrant tachycardia, previous
studies (5) have shown that adenosine may terminate the
tachycardia either by causing block in the anterograde slow
pathway or in the retrograde fast pathway. Although observa-
tions in clinical studies (6) have suggested that adenosine is
more potent in slowing anterograde than retrograde conduc-
tion through the AV node, the relative responsiveness of
anterograde fast and slow pathway conduction to adenosine
has not been investigated. The purpose of the present study
was to determine whether the depressant effect of adenosine
on the anterograde fast pathway is more pronounced than the
effect on the slow pathway in patients with typical AV node
reentrant tachycardia who have demonstrable dual AV node
pathways. As a corollary to this first objective, the second aim
of this investigation was to determine whether low doses of
adenosine, by briefly blocking fast pathway conduction, could
be used to initiate AV node reentrant tachycardia.
Methods
Protocol. All patients undergoing electrophysiologic stud-
ies for the diagnosis and radiofrequency ablation of supraven-
tricular tachycardia were invited to participate in the study.
The study was approved by the institutional review board of
the University of Florida, and all patients gave informed
consent. Patients were studied in the fasting state after all
antiarrhythmic drugs had been discontinued for at least 5
half-lives. Three quadripolar catheters were inserted through
sheaths in the femoral veins and advanced to the right ventric-
ular apex, the high right atrium and the His bundle position,
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respectively. A decapolar catheter was placed in the coronary
sinus through a subclavian vein in selected patients. Baseline
atrial, AV node and ventricular refractory periods were deter-
mined in each patient, and incremental atrial and ventricular
pacing were performed. Supraventricular tachycardia was in-
duced by using atrial or ventricular extrastimuli or by atrial
burst pacing. The mechanism of the tachycardia was deter-
mined using standard criteria.
All patients who had consented to participate in the study
and who had dual AV node pathways and typical AV node
reentrant tachycardia underwent the adenosine protocol be-
fore radiofrequency ablation of the slow pathway. Dual AV
node pathways were considered to be present when there was a
sudden increase $50 ms in the AH interval for a 10-ms
decrement in the A1–A2 coupling interval (7). Eligible patients
received incremental doses of adenosine during atrial pacing at
a cycle length that was determined by adding ;40 ms to the
effective refractory period of the fast pathway to achieve steady
state conduction over the fast pathway. Adenosine was admin-
istered at increasing doses of 1, 2, 4, 6, 9, 12 and 18 mg, or until
AV block occurred. The adenosine was administered rapidly
into a peripheral intravenous line, followed by an immediate
saline flush. At least 2 min was allowed to elapse between
injections of adenosine. In two patients in whom administra-
tion of low doses of adenosine during atrial pacing led to
initiation of AV node reentrant tachycardia, atrial pacing was
discontinued, and higher doses of adenosine were adminis-
tered during the same episode of tachycardia to terminate it.
Intracardiac recordings were obtained throughout the pe-
riod of administration of adenosine until the AH interval
returned to baseline. The signals were filtered at 30 to 500 Hz
and stored on an optical disk (Quinton Electrophysiology,
Ontario, Canada) for later analysis. The longest AH interval
achieved for each dose of adenosine was determined; in
addition, any abrupt changes in AH interval were noted.
After the adenosine protocol was completed, all patients
successfully underwent radiofrequency ablation of the slow
pathway.
In addition to the patients with dual AV node pathways, 10
patients without known supraventricular tachycardia and with
no electrophysiologic evidence for dual AV node pathways
who were undergoing electrophysiologic studies for syncope or
ventricular arrhythmias were also given incremental doses of
adenosine during atrial pacing at cycle lengths of 50 and
100 ms longer than the Wenckebach cycle length.
Statistical analysis. Results are expressed as mean value 6
SD. The Student paired t test was used to compare the mean
doses of adenosine required to block the fast and the slow AV
node pathways, with a p value #0.05 taken as evidence of a
significant difference. Regression analysis was used to deter-


























1/F 42 709 72 400 337 ,246 280 1 4
2/F 55 850 75 500 342 ,278 360 12 #12
3/F 35 713 41 400 302 ,259 290 2 4
4/F 41 913 68 500 390 278 350 1 6
5/M 60 784 75 500 315 256 320 2 6
6/F 62 690 75 600 344 ,282 370 1 4
7/F 47 780 69 500 396 323 AVNRT 2 6
8/M 62 891 62 600 482 293 AVNRT 1 3




10/F 75 713 81 500 363 ,212 No 6 9
11/F 62 522 66 400 292 ,220 Yes 4 ND
12/F 58 637 97 500 360 ,280 No 1 ND
13/F 72 731 87 500 356 294 Yes 1 ND
14/F 34 694 72 400 281 262 Yes 1 ND
15/F 42 772 91 500 375 325 Yes 1 ND
16/F 83 734 103 500 308 ,290 Yes 1 ND
*Mean† 54 729 74 344 272 2.7 7.2
6SD† 615 6108 616 653 631 63.0 64.7
*p 5 0.009 for Group 1, p 5 0.004 including Patient 10. †Values are from both Groups 1 and 2. AVNRT 5
atrioventricular (AV) node reentrant tachycardia; CL 5 cycle length; ERP 5 effective refractory period; F 5 female;
Group 1 5 fast and slow pathway responsiveness to adenosine; Group 2 5 induction of AV node reentrant tachycardia
with adenosine; M 5 male; ND 5 not done; Pt 5 patient; WCL 5 Wenckebach cycle length.
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mine the correlation between the dose of adenosine required
to cause conduction block of the pathway and the effective
refractory period of the fast and slow pathways.
Results
Patient characteristics. A total of 26 patients were en-
rolled in the study (16 with dual AV node pathways and AV
node reentrant tachycardia; 10 with no evidence for dual AV
node pathways and no inducible supraventricular tachycardia).
Among the 16 patients with dual AV nodal pathways (14
women, 2 men; mean age 54 6 15 years), there was 1 woman
with mitral valve prolapse 1 man with hypertrophic cardiomy-
opathy; the other 14 patients had structurally normal hearts.
The 16 patients with dual AV node pathways were classified
into two groups: Group 1 (n 5 9) received incremental doses
of adenosine until AV block occurred; Group 2 (n 5 7)
received increasing doses of adenosine only until fast pathway
block occurred, with the primary aim of inducing AV node
reentrant tachycardia. Baseline electrophysiologic data for
both groups are summarized in Table 1. Two patients had
repeated induction of AV node reentrant tachycardia with
incremental atrial pacing, making it difficult to determine the
Wenckebach cycle length.
Refractory periods and response to adenosine. Among the
16 patients with dual AV node pathways, the mean effective
refractory period of the fast pathway was 344 6 53 ms (range
263 to 482) versus an upper limit of 272 6 31 ms for the slow
pathway (range ,212 to 325). In nine of the patients studied,
the effective refractory period of the slow pathway could not be
precisely determined because of atrial refractoriness. There
was a significant difference between the mean doses of aden-
osine required to block conduction through the fast and the
slow AV node pathways. In Group 1, conduction in the fast
pathway blocked at a mean dose of 3.1 6 3.7 mg (median dose
2.0), whereas conduction in the slow pathway blocked at a
mean dose of 7.0 6 4.9 mg (median dose 6.0). This difference
was highly significant at p 5 0.009. Among all the patients, the
Figure 1. A, AV node refractory period determination demonstrating
typical dual AV node pathways in Patient 9 (Group 1), with an abrupt
increase of 94 ms in the AH interval at an A1–A2 coupling interval of
263 ms. At A1–A2 coupling intervals #252 ms, AV node reentrant
tachycardia was induced. B, Relation between AH interval and dose of
adenosine for the same patient during atrial pacing at a cycle length of
350 ms. For doses up to 5 mg, the AH interval ranged from 73 to
100 ms. At doses $6 mg, the AH interval abruptly increased to 245 ms
throughout the time course of adenosine effect, then abruptly returned
to the original value. Doses $10 mg led to the initiation of AV node
reentrant tachycardia. AV block did not occur even with 18 mg of
adenosine. C, AV node refractory period determination in a control
patient, demonstrating a gradual increase in A2–H2 interval with
decreasing A1–A2 coupling interval. D, Relation between AH interval
and dose of adenosine for the same patient during atrial pacing at a
cycle length of 450 ms. There is little change in the AH interval with
increasing doses of adenosine, until AV block occurs at the dose of 6 mg.
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fast pathway blocked at a mean dose of adenosine of 2.7 6
3.0 mg (median dose 1.0).
A representative example of a patient with dual AV nodal
pathways and the effect of adenosine on the AH interval is
illustrated in Figure 1. Fig. 1A depicts an abrupt increase in the
AH interval at an A1–A2 coupling interval of 263 ms during
the AV node refractory period determination. Figure 1B shows
that in the same patient, the AH interval was 64 ms and
changed little (73 to 100 ms) during administration of 1- to
5-mg doses of adenosine while pacing the atrium at a cycle
length of 350 ms. At a dose of 6 mg, there was an abrupt
increase in the AH interval to 245 ms that persisted for 14 s
before abruptly returning to baseline. Higher doses of adeno-
sine (i.e., 7 to 18 mg) also led to abrupt increases in the AH
interval to 245 ms. When 10 to 18 mg of adenosine was given,
AV node reentrant tachycardia was initiated. In this patient,
AV block was not seen, even at the 18-mg dose of adenosine.
Although the effect of adenosine on fast pathway conduction
that was seen in this patient was typical of that observed
throughout the study, this patient required markedly higher
doses of adenosine to block conduction in the fast pathway
than were necessary in the other patients (Table 1).
Control patients. Ten patients without evidence of dual
AV node pathways or a history of supraventricular tachycardia
were studied as well. In these patients, administration of
increasing doses of adenosine was associated with little change
in the AH interval, until AV block occurred at a mean
adenosine dose of 7.5 6 1.7 mg. A typical example is illustrated
in Figure 1, C and D.
Block of fast pathway conduction with adenosine. The
abrupt prolongation of the AH interval caused by adenosine in
the patients with dual AV node pathways is shown in Figure 2.
Fig. 2A illustrates a sudden increase in AH interval within a
single beat (from 115 to 194 ms), whereas the abrupt return of
the AH interval to baseline (from 180 to 95 ms) as the effect of
adenosine wore off is shown in Figure 2B.
Figure 2. Representative recording of the effect of
adenosine on AV conduction during atrial pacing in
Patient 9 (Group 1). A, There is an abrupt increase in
the AH interval from 115 to 194 ms after a 6-mg
intravenous bolus injection of adenosine during atrial
pacing at 350 ms. B, The AH interval abruptly shortens
from 180 to 95 ms as the adenosine effect dissipates.
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The data for the patients with dual AV node pathways in
Group 1 in whom both fast and slow pathway responsiveness to
adenosine were tested are summarized in Figure 3. In eight of
nine patients, conduction block occurred in the fast pathway
before the slow pathway, as depicted by the abrupt increase in
AH interval with a small increment in the dose of adenosine.
This greater responsiveness of the fast than the slow pathway
to adenosine was also observed in six of seven patients in
Group 2 tested primarily to induce AV node reentrant tachy-
cardia. Hence, adenosine caused fast pathway conduction
block before slow pathway conduction block in 14 of the 16
patients studied. The two patients who did not show this
pattern had clear evidence of dual AV node pathways at
baseline, yet they showed only a gradual increase in AH
interval with increasing doses of adenosine until AV block
occurred at adenosine doses of 18 and 9 mg, respectively.
The relation between the dose of adenosine required to
block conduction in the fast or the slow AV node pathway and
the effective refractory period of each pathway is shown in
Figure 4. There was a clear inverse correlation between the
effective refractory period of the pathway and the dose of
adenosine required to block the pathway, with a correlation
coefficient of 0.94. That is, the longer the refractory period of
the pathway, the lower the dose of adenosine required to cause
block.
Induction of AV node reentrant tachycardia with adeno-
sine. Of interest was the observation that in many patients,
administration of doses of adenosine lower than those required
to cause AV block actually led to the induction of AV node
reentrant tachycardia. For instance, 9 of the 16 patients with
dual AV node pathways developed AV node reentrant tachy-
cardia with the administration of 1 to 10 mg of adenosine
(mean 3.2 6 2.9, #4 mg in all but 1 patient), respectively,
whereas 1 additional patient showed single echo beats after
administration of 2 and 4 mg of adenosine. In two of the
patients, after adenosine was given during atrial pacing to
initiate AV node tachycardia, atrial pacing was discontinued,
and a higher dose of adenosine was given, which led to
termination of the same tachycardia (Fig. 5).
Discussion
The results of the present study demonstrate that the fast
and the slow AV node pathways are not equally responsive to
adenosine. In most patients with dual AV node pathways, the
anterograde fast pathway is more responsive to the effects of
adenosine than the anterograde slow pathway. In addition,
because of this differential responsiveness of the fast and slow
pathways, adenosine can be used both to initiate and to
terminate AV node reentrant tachycardia.
Effects of adenosine on anterograde and retrograde AV
node conduction. Previous investigators (5) have shown that
adenosine can terminate typical AV node reentrant tachycar-
dia by causing conduction block either in the anterograde slow
pathway or the retrograde fast pathway, or both. Other studies
Figure 4. Correlation between the effective refractory period of the
fast and slow AV node pathways and the dose of adenosine required
to block the pathway. There is an inverse correlation between the dose
of adenosine and the refractoriness of the pathway, with a correlation
coefficient r 5 0.94.
Figure 3. Relation between AH interval and dose
of adenosine in Group 1 patients. In all except
Patient 2, the fast pathway blocked with low doses
of adenosine, whereas the slow pathway required
higher doses.
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(6) have suggested that adenosine is more potent in blocking
anterograde conduction through the AV node than retrograde
conduction. Adenosine decreases the amplitude and duration
of the action potentials of AN and N cells in the AV node, but
not NH cells (8). The N zone of the AV node is the most likely
site of conduction block caused by adenosine. Hence, the fact
that adenosine markedly decreases the amplitude and shortens
the action potential duration of AN cells but not NH cells is
consistent with the observation that adenosine is more potent
in blocking anterograde than retrograde conduction.
Effects of adenosine on anterograde fast and slow AV node
pathways. Impulse propagation through the anterograde fast
and slow AV node pathways enters into the compact AV node.
Given the longer conduction time of the slow pathway than the
fast pathway and the known site of action of adenosine in the
AV node, it could be predicted that the slow AV node pathway
would be more sensitive to the effects of adenosine than the
fast pathway. Our results show just the opposite. It is thus
possible that either the fast pathway involves the compact
AV node to a greater extent than previously realized, or that
the relative amount of input of each pathway into the
compact AV node is irrelevant in explaining its responsive-
ness to adenosine.
A recent preliminary study (9) on the effect of adenosine on
anterograde fast and slow pathway conduction found that a
higher dose of adenosine was required to cause AV block
before slow pathway ablation than after ablation was accom-
plished. This finding and the observation by the same investi-
gators that administration of adenosine caused an abrupt
increase in the AH interval without induction of AV block are
both consistent with the results of our study.
Refractoriness and response to adenosine. An alternative
explanation for the greater sensitivity of the fast pathway to
adenosine may be that refractoriness of the pathway rather
than conduction is the more important determinant of respon-
siveness to adenosine. This hypothesis is supported by our
Figure 5. Initiation and termination of AV node
reentrant tachycardia with adenosine in the same
patient. A, During atrial pacing at a cycle length of
430 ms, after intravenous administration of 4 mg of
adenosine, there is an abrupt prolongation of the AH
interval (arrow), followed by initiation of the tachy-
cardia (asterisk). The tachycardia persisted after
pacing was discontinued. B, During the same episode
of AV node reentrant tachycardia, intravenous ad-
ministration of 12 mg of adenosine led to termina-
tion of the tachycardia by block in the slow pathway.
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finding that conduction through pathways with long effective
refractory periods is blocked with lower doses of adenosine
than pathways with shorter refractory periods. In support of
this explanation, it is known that adenosine and A1 adenosine
receptor agonists increase refractoriness in AV node tissue
(10,11). However, it should be noted that the significant
inverse relation between the refractory period of an AV node
pathway and the dose of adenosine required to block conduc-
tion through that pathway does not in itself prove causality.
Mechanism of action of adenosine in AV node reentrant
tachycardia. A hypothesis to explain the induction of AV
node reentrant tachycardia with adenosine is that low doses of
adenosine that selectively and briefly block fast pathway con-
duction allow conduction antegradely through the slow path-
way only. Retrograde conduction up the fast pathway then sets
up the reentrant circuit for AV node reentry. That induction of
AV node reentrant tachycardia is not often seen clinically is
simply due to the fact that large doses of adenosine are
routinely administered that cause unselective conduction block
of both AV node pathways and, thereby, termination of AV
node reentrant tachycardia.
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